S&P ASX All Technology

3,137.90

0.55%

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Genenta Science SPA (GNTA)
Genenta Science SPA (GNTA) News

GNTA

Genenta Science (GNTA)

Genenta Science SPA

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GNTA

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
06/05/2024	20:25	GlobeNewswire Inc.	Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider	NASDAQ:GNTA	Genenta Science SPA
13/02/2024	08:05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GNTA	Genenta Science SPA
08/02/2024	21:00	GlobeNewswire Inc.	Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors	NASDAQ:GNTA	Genenta Science SPA
21/10/2023	07:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNTA	Genenta Science SPA
06/09/2023	21:00	GlobeNewswire Inc.	Genenta to Present at Upcoming Scientific and Investor Conferences	NASDAQ:GNTA	Genenta Science SPA
28/07/2023	17:00	GlobeNewswire Inc.	Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments	NASDAQ:GNTA	Genenta Science SPA
29/06/2023	21:00	GlobeNewswire Inc.	The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma	NASDAQ:GNTA	Genenta Science SPA
25/05/2023	20:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:GNTA	Genenta Science SPA
16/05/2023	21:00	GlobeNewswire Inc.	Genenta to Provide Update on Lead Product Temferon™	NASDAQ:GNTA	Genenta Science SPA
13/05/2023	07:13	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	NASDAQ:GNTA	Genenta Science SPA
02/05/2023	06:06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
26/04/2023	21:00	GlobeNewswire Inc.	Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing	NASDAQ:GNTA	Genenta Science SPA
22/04/2023	07:23	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:GNTA	Genenta Science SPA
11/03/2023	08:49	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
10/02/2023	22:10	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:GNTA	Genenta Science SPA
02/02/2023	09:29	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
23/12/2022	08:12	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
27/10/2022	09:45	TipRanks	Maxim Group Remains a Buy on Genenta Science SpA Sponsored ADR (GNTA)	NASDAQ:GNTA	Genenta Science SPA
26/10/2022	08:14	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
03/10/2022	22:17	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
25/07/2022	20:00	GlobeNewswire Inc.	AmCham Italy and Genenta Science Announce the Bowling Green Bull Initiative	NASDAQ:GNTA	Genenta Science SPA
15/06/2022	07:12	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
16/06/2009	00:47	PR Newswire (US)	The following is an investment opinion release issued by EmergingStockReport.com	NASDAQ:GNTA
16/05/2009	00:48	PR Newswire (US)	Stock Alerts on Market Movers: NGRN, RMBS, NVLS, LVS, GNTA, AN; Issued by Beacon Equity	NASDAQ:GNTA
07/03/2009	11:36	Dow Jones News	Genta: FDA Favors Clinical Trial For Leukemia Drug Genasense	NASDAQ:GNTA	Genta Inc.
07/03/2009	10:34	Business Wire	FDA Appeal Decision Indicates that Genasense® Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory ...	NASDAQ:GNTA	Genenta Science SPA
14/02/2009	08:10	Business Wire	Genta Incorporated Announces Fourth Quarter and Year End 2008 Financial Results and Corporate Highlights	NASDAQ:GNTA	Genenta Science SPA
08/01/2009	05:02	PR Newswire (US)	Beacon Equity Issues Technical Trade Alerts on Newsworthy Market Movers: WLT, SSCC, FNSR, CHTR, STSI, GNTA	NASDAQ:GNTA
15/09/2008	22:05	PR Newswire (US)	Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma	NASDAQ:GNTA
07/08/2008	22:00	PR Newswire (US)	Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights	NASDAQ:GNTA